A

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Student Assistant for Treasury Intern

TreasuryConfirmed live in the last 24 hours
InternshipHellerup, DenmarkNo salary listed

About the Job

Requirements

  • Be currently enrolled in a relevant academic program within Finance, Economics, Business Administration, Accounting, or a similar field.
  • Have strong analytical skills and a flair for numbers.
  • Use a structured approach and demonstrate attention to detail.
  • Be reliable and able to handle recurring deadlines.
  • Demonstrate curiosity, sound judgment, and willingness to learn.
  • Have strong Excel and PowerPoint skills.
  • Be proficient in written and spoken English.

Responsibilities

  • Prepare analyses, presentations, and documentation supporting treasury policies, investment strategy, and the Group’s approach to financial risk.
  • Support daily liquidity monitoring, cash positioning, cash pool activities, cash flow forecasting, working capital analysis, and monitoring of financial investments.
  • Support analysis and documentation related to capital structure, bank funding, debt agreements, and convertible notes.
  • Monitor Group foreign exchange exposures and support foreign exchange transactions for liquidity and risk management purposes.
  • Prepare recurring treasury reporting and explain developments in treasury-related profit and loss and balance sheet items.
  • Support bank administration, documentation, and follow-up with the Group’s relationship banks.
  • Contribute to treasury projects, data analysis, process documentation, and automation initiatives.

Desired Qualifications

  • Be at the end of a bachelor’s degree or beginning a master’s degree.
  • Have experience with ERP systems, financial data, Power BI, Power Automate, or similar tools.

About the Company

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Ascendis Pharma uses its TransCon technology to create long-acting prodrugs for rare endocrine diseases, with expansions into oncology and ophthalmology. The platform temporarily attaches an unmodified drug to an inert carrier and releases the active drug in a predictable, sustained way after injection, reducing how often patients must dosing. It differentiates itself through a proprietary delivery system and a track record that includes marketed therapies like SKYTROFA for pediatric growth hormone deficiency and YORVIPATH for hypoparathyroidism, along with collaborations such as a Novo Nordisk deal. The company aims to improve patient outcomes by enabling easier, less frequent dosing while expanding its pipeline across rare endocrine diseases, cancer, and eye diseases.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
2007

Recently Posted Jobs

Explore more opportunities at Ascendis Pharma

See more jobs